The aim of this study was to clarify the clinical characteristics of patients with Helicobacter cinaedi bacteremia and the time required for blood cultures to become positive. The medical records of all patients with H. cinaedi bacteremia at Toranomon Hospital and Toranomon Hospital Kajigaya between March 2009 and March 2013 were retrospectively reviewed. Sixty-three patients, 34 men and 29 women with a median age of 67 years (range, 37 to 88 years), were diagnosed with H. cinaedi bacteremia. A total of 51,272 sets of blood cultures were obtained during the study period, of which 5,769 sets of blood cultures were positive for some organism and 126 sets were H. cinaedi positive. The time required for blood cultures to become positive for H. cinaedi was <5 days in 69 sets (55%) and >5 days in 57 sets (45%). Most patients had an underlying disease, including chronic kidney disease (21 cases), solid tumor (19 cases), hematological malignancy (13 cases), diabetes mellitus (8 cases), chronic liver disease (6 cases), and postorthopedic surgery (3 cases). Only 1 patient had no apparent underlying disease. The clinical symptoms included cellulitis in 24 cases, colitis in 7 cases, and fever only in 27 cases, including 7 cases of febrile neutropenia. The 30-day mortality rate of H. cinaedi bacteremia was 6.3%. In conclusion, most cases of H. cinaedi bacteremia occurred in immunocompromised patients. We might have overlooked nearly half of the H. cinaedi bacteremia cases if the duration of monitored blood culture samples had been within 5 days. Therefore, when clinicians suspect H. cinaedi bacteremia, the observation period for blood cultures should be extended.
H
elicobacter cinaedi is a Gram-negative spiral bacillus that causes enteric or bloodstream infections. H. cinaedi has been associated with gastroenteritis in homosexual men (1) . Recently, H. cinaedi was detected in the blood cultures of immunocompromised patients, and it has frequently been reported as bacteremia (2) (3) (4) (5) . However, few reports have assessed the frequency of H. cinaedi bacteremia, the clinical characteristics of patients with H. cinaedi bacteremia, or the number of days required to detect H. cinaedi by blood culture. The aim of this study was to clarify the clinical characteristics of patients with H. cinaedi bacteremia and the time required for blood cultures to become positive.
MATERIALS AND METHODS
The medical records of all patients with H. cinaedi bacteremia at Toranomon Hospital (Tokyo, Japan) (890 beds) and Toranomon Hospital Kajigaya (Kanagawa, Japan) (300 beds) between March 2009 and March 2013 were retrospectively reviewed. Blood culture samples were processed using the Bactec 9240 (between March 2009 and March 2013) and the Bactec FX (between June 2010 and March 2013) systems (Becton, Dickinson and Company, Sparks, MD, USA). All of the samples were routinely monitored for at least 7 days (between 7 and 8 days). If the blood cultures were obtained from patients who had H. cinaedi bacteremia previously, the bottles were blindly subcultured aerobically and anaerobically on day 7 and were monitored for another 7 days. Also, if blood cultures were obtained from the patients who had unexplained fever and the clinicians requested to extend the observation period for blood cultures, the bottles were monitored for a total of 14 days. A microaerobic culture was conducted with chocolate II agar (Nippon Becton, Dickinson, and Company, Tokyo, Japan) and Trypticase soy agar II with 5% sheep blood (Nippon Becton, Dickinson and Company) at 35°C for 7 days to identify H. cinaedi infection when positive blood cultures and Gram-negative spiral bacilli were found or when positive blood cultures on anaerobic bottles and no organisms were found on Gram staining. Stool samples were obtained when positive blood cultures and Gram-negative spiral bacilli were found. A microaerobic culture of stool samples was conducted in modified Skirrow medium EX (Nissui Pharmaceutical Co., Tokyo, Japan) at 35°C for 7 days. H. cinaedi was identified using gyrB-targeted PCR methods (195 bp; forward primer, AGGGATTCCACAAAGTGAGC, and reverse primer, TCTTGTCCTGTGCGTTCATC) (6) .
Overall 30-day mortality was defined as the rate of patients who died within 30 days after the onset of H. cinaedi bacteremia. Chronic kidney disease was defined as a serum creatinine concentration of Ն2.0 mg/dl. Chronic liver disease was defined as liver cirrhosis or chronic hepatitis B or C infection. Nosocomial bloodstream infection, health care-associated bloodstream infection, community-acquired bloodstream infection, and febrile neutropenia were defined as described elsewhere (7, 8) . Recurrence was defined as evidence of H. cinaedi bacteremia after documenting negative blood cultures or clinical improvements following the completion of a course of anti-H. cinaedi therapy.
This study was approved by the Human Ethics Review Committee of Toranomon Hospital.
RESULTS
Sixty-three patients, 34 men and 29 women with a median age of 67 years (range, 37 to 88 years), were diagnosed with H. cinaedi bacteremia during the 4-year study period. A total of 51,272 sets of blood cultures were obtained during the study period, of which 5,769 sets of blood cultures were positive for some organism and 126 sets were H. cinaedi positive. All H. cinaedi strains were detected in aerobic bottles only. The underlying diseases are shown in Table 1 . Underlying diseases included chronic kidney diseases (21 cases, including 12 patients undergoing hemodialysis), solid tumors (19 cases), hematological malignancies (13 cases), diabetes mellitus (8 cases), chronic liver diseases (6 cases), postorthopedic surgery (3 cases), and others (5 cases). Solid tumors were in patients with gallbladder/bile duct (4 cases), esophagus (3 cases), liver (3 cases), colon (2 cases), bladder/ureter (2 cases), ovary (2 cases), lung (2 cases), pancreas (1 case), breast (1 case), and brain (1 case) cancers. Only 1 case had no apparent underlying disease. Of the 63 cases, 25 (40%) were receiving chemotherapy for cancer when H. cinaedi bacteremia occurred. We screened for HIV-1/2 infection in 48 cases by enzyme-linked immunosorbent assay (ELISA), and all patients were HIV negative. Of the 63 cases, 2 had community-acquired bloodstream infection, 29 had health careassociated bloodstream infection, and 32 had nosocomial bloodstream infection.
The times required for blood cultures to become positive are shown in Fig. 1 . The median time was 5 days (range, 2 to 12 days). The times for blood cultures to become positive were Յ5 days in 69 sets (55%) and Ͼ5 days in 57 sets (45%).
Clinical symptoms included cellulitis (24 cases), colitis (7 cases), fever only (27 cases, including 7 cases of febrile neutropenia), and others (5 cases) ( Table 1) . Most of the cases of cellulitis presented with unclear border erythema and tenderness in the lower extremities. We obtained stool samples from 41 patients, and the stool cultures from 24 of them were positive for H. cinaedi. The overall 30-day mortality rate of H. cinaedi bacteremia in this study was 6.3% (4/63). Recurrent bacteremia occurred in 15 cases (24%).
DISCUSSION
This is the largest case series describing the clinical characteristics of H. cinaedi bacteremia. H. cinaedi infections are generally detected by blood cultures. To date, few studies have described the epidemiology of H. cinaedi bacteremia. The epidemiology of H. cinaedi bacteremia in Japan was prospectively studied using blood cultures for 6 months, from October 2003, at 13 facilities (9). Of the 16,743 blood cultures submitted during the observation period, 2,718 sets (17.7%) were positive, and 6 (0.036%) were positive for H. cinaedi (9) . Six cases were detected at three facilities. The isolation frequencies varied with the facilities. H. cinaedi is often misidentified as a Campylobacter sp. because of difficulties associated with discriminating H. cinaedi from Campylobacter spp. (9) . Additionally, it is difficult to distinguish H. cinaedi from other enterohepatic helicobacters. H. cinaedi appears as a thinspread colony and shows no hemolysis on sheep blood agar. H. cinaedi has several biochemical characteristics, i.e., it lacks urease activity and is catalase positive, oxidase positive, nitrate positive, indoxyl acetate hydrolysis negative, alkaline phosphatase negative, and ␥-glutamyl transpeptidase negative (10) . It is generally known that H. cinaedi shows growth at 35°C and no growth at 25°C or 42°C (10). However, several previous reports described H. cinaedi growing at 42°C (9) . It is impossible to identify H. cinaedi based on these biochemical characteristics only. Thus, a definitive diagnosis of H. cinaedi requires PCR identification.
H. cinaedi was positive in 0.25% (126 of 51,272) of all blood cultures and 2.2% (126/5,769) of blood culture-positive cases in our study. Therefore, this study revealed that the incidence of H. cinaedi bacteremia in our hospital was higher than that in a previously reported multicenter study in Japan (9). To our knowledge, no epidemiological findings have been obtained from countries other than Japan, which suggests that H. cinaedi bacteremia may be more common in Japan; however, this is speculation and should be investigated further.
In the present study, underlying diseases were more common in severely immunocompromised patients with chronic kidney diseases, solid tumors, hematological malignancies, or cellular immune deficiencies. Intra-abdominal tumors were the most com- However, H. cinaedi bacteremia may be overlooked in healthy patients because it cannot be diagnosed without collecting blood cultures. None of our patients were HIV positive. Further investigations are needed in areas outside Japan because the prevalence of HIV infection is not high in our country. More cases of H. cinaedi bacteremia are expected to be accumulated in the future, and the risk factors for H. cinaedi bacteremia should be clarified. Blood culture bottles from patients with H. cinaedi bacteremia became positive in a median of 5 days (range, 2 to 12 days). The observation period for blood cultures ranges from 5 to 7 days at most facilities and is typically 5 days. Therefore, we may be overlooking nearly half of H. cinaedi bacteremia cases if the duration of monitoring blood culture samples is within 5 days. The observation period should be extended to at least 7 days in areas where it is endemic, such as facilities with high isolation frequencies of H. cinaedi. Our study showed that 110 of 126 isolates (87%) were obtained within 7 days of incubation. In terms of cost-effectiveness, it is not recommended that the observation period for all blood cultures be 14 days. However, when clinicians suspect H. cinaedi bacteremia, the observation period for blood cultures may be extended to up to 14 days. Cellulitis was the most common clinical symptom; however, 27 patients (including 7 with febrile neutropenia) had fever without any recognizable focus of infection. Thus, H. cinaedi should be considered a causative pathogen of unexplained fever in immunocompromised patients.
The mortality rate of patients with H. cinaedi bacteremia was not high in this study, and this is the first report to provide data on prognoses. Various antimicrobial agents were administered in the study, and no specific trend associated with therapeutic effects was observed. Since no standard measurement method has been established for drug susceptibility, its breakpoint should be determined in the future.
The route of H. cinaedi infection is not clear but is often thought to be fecal-oral. H. cinaedi colonizes the gastrointestinal tract, and bacterial translocation may lead to the development of bacteremia associated with mucosal damage. Among 43 cases, we confirmed that 24 (56%) were H. cinaedi positive from the results of a stool examination. This is the first report to describe the positivity rate for H. cinaedi in the stool of patients with H. cinaedi bacteremia. Most stool samples were obtained after empirical antibiotic treatment was initiated. Therefore, it is possible that most of the patients had H. cinaedi in their gastrointestinal tracts. H. cinaedi might have presented as transient bacteremia in immunocompromised patients, especially in the 27 patients with only fever. Also, recent studies suggested that H. cinaedi may cause recurrent bacteremia (12) (13) (14) , which was reported in 15 patients (24%) in the current study. The reason recurrent bacteremia occurs in specific cases remains unknown; however, H. cinaedi in the gastrointestinal tract may be associated with recurrent bacteremia.
This study had some limitations. First, it was a retrospective and single-center study. The prevalence rate of H. cinaedi was 2.2% of blood culture-positive cases. However, this might underestimate the true incidence of H. cinaedi. As shown in Fig. 1 , 16/ 126 isolates (13%) were obtained after Ͼ7 days of incubation.
Incubation of these cultures was prolonged because either (i) the patients had previous H. cinaedi-positive cultures or (ii) clinicians requested extended blood cultures. As shown in Table 1 , 27 of 63 cases presented with a nonspecific clinical presentation (only fever of unknown origin). Therefore, additional cases may have been identified if incubation of all the blood cultures had been longer. Second, we could not exclude the possibility that person-to-person H. cinaedi transmission occurred. However, no apparent outbreak of H. cinaedi infection occurred during the study period. Moreover, nearly half of the patients examined (31/63) had health care-associated bloodstream infection and community-acquired bloodstream infection, while the other half had nosocomial bloodstream infection.
In conclusion, most cases of H. cinaedi bacteremia occurred in immunocompromised patients. H. cinaedi should be considered the causative pathogen of unexplained fever in areas of endemicity. We might have overlooked nearly half of the H. cinaedi bacteremia cases if the duration of monitored blood culture samples had been within 5 days. When clinicians suspect H. cinaedi bacteremia, the observation period of blood cultures should be extended.
